Skip to main content
$90.48 -$0.53 (-0.6%)

04:00 PM EST on 01/21/22

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 3 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Current Price $90.48 Mkt Cap $5.6B
Open $91.00 P/E Ratio 0.00
Prev. Close $90.48 Div. (Yield) $0.00 (0.0%)
Daily Range $90.45 - $91.38 Volume 1,762,032
52-Wk Range $45.50 - $94.23 Avg. Daily Vol. 1,814,352

Caps

How do you think NASDAQ:ARNA will perform against the market?

Add Stock to CAPS Watchlist

All Players

751 Outperform
66 Underperform
 

All-Star Players

90 Outperform
10 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ARNA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

JaxPicks (61.85)
Submitted January 17, 2020

Several unique therapies showing promise in trials for large unaddressed diseases.

opgenortht (< 20)
Submitted April 22, 2010

obesity market for drugs without significant sustained weight loss - greater than 10% - is impossible to penetrate without gigantic consumer-directed, expensive, advertising....remember 10% for a 250lb person is 25lb bringing their new weight to… More

NASDAQ:ARNA VS S&P 500 (SPY)

Fools bullish on NASDAQ:ARNA are also bullish on:

Fools bearish on NASDAQ:ARNA are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about ARNA.

Recs

2
Member Avatar JaxPicks (61.85) Submitted: 1/17/2020 9:27:54 AM : Outperform Start Price: $46.55 NASDAQ:ARNA Score: +62.37

Several unique therapies showing promise in trials for large unaddressed diseases.

Recs

1
Member Avatar Capitalism (87.37) Submitted: 9/19/2018 11:51:53 AM : Outperform Start Price: $41.93 NASDAQ:ARNA Score: +65.61

bulwnkl from Saul's MF msg board

Recs

1
Member Avatar TMFEBCapital (83.90) Submitted: 2/15/2018 12:02:45 PM : Outperform Start Price: $39.94 NASDAQ:ARNA Score: +64.79

Big potential catalyst on deck in the form of results from a mid stage trial evaluating a drug with the same mechanism of action as Celgene's ozanimod. If ARNA's trial is a success, shares are likely to trade meaningfully higher. A disappointment could cause a plunge, though, so buyer beware.

Leaderboard

Find the members with the highest scoring picks in ARNA.

Score Leader

bluemoth

bluemoth (< 20) Score: +757.14

The Score Leader is the player with the highest score across all their picks in ARNA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
neallp31 49.45 11/18/2016 Outperform 5Y $15.40 +489.35% +101.32% +388.03 0 Comment
whitebonez 30.99 4/5/2011 Outperform 5Y $13.35 +579.85% +229.42% +350.43 0 Comment
Geode59 < 20 11/18/2010 Outperform 5Y $12.75 +611.84% +266.15% +345.69 0 Comment
rruz < 20 10/30/2015 Outperform 5Y $16.50 +450.06% +110.71% +339.35 0 Comment
WiseWillyAgain 59.39 7/5/2017 Outperform 5Y $17.46 +419.82% +81.23% +338.59 1 Comment
MaBrandao < 20 3/21/2016 Outperform 1Y $16.40 +453.41% +115.47% +337.94 0 Comment
palinkrk < 20 4/8/2011 Outperform 1Y $13.72 +561.71% +230.24% +331.47 0 Comment
EricMendelsohn < 20 6/6/2011 Outperform 1Y $13.80 +557.68% +238.00% +319.68 0 Comment
loptey < 20 5/24/2011 Outperform 5Y $14.00 +548.29% +232.01% +316.28 0 Comment
pastordisaster < 20 11/17/2010 Outperform 5Y $13.20 +587.58% +271.41% +316.17 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ARNA.